2018 CCR p95 in 2 mayo trials | Integrated Oncology

LabCorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.

Date Posted

Sun, 03/18/2018 - 12:00

Publication

Clinical Cancer Research

Poster Title

p95HER2 Methionine 611 Carboxy-Terminal Fragment Is Predictive of Trastuzumab Adjuvant Treatment Benefit in the FinHer Trial

Author

Jeff Sperinde,Weidong Huang, Aki Vehtari, Ahmed Chenna,
Pirkko-Liisa Kellokumpu-Lehtinen, John Winslow, Petri Bono,
Yolanda S. Lie, Christos J. Petropoulos, Jodi Weidler, and Heikki Joensuu

PDF

2018_ccr_p95_in_2_mayo_trials.pdf460.43 KB

Type

Article